Health
Hematopoietic stem cell transplants may provide long-term benefit for people with MS – EurekAlert
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS)…
MINNEAPOLIS – A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after…
-
General19 hours agoRestaurants on the brink as business failures plateau
-
General8 hours agoThree maps that show the scale of the NSW flood disaster
-
General23 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General19 hours agoRegional house price growth outstrips capital cities